<html><head>
<meta http-equiv="Content-Type" content="text/html; charset=utf-8">
</head><body>
<span style="position:absolute; border: gray 1px solid; left:0px; top:50px; width:612px; height:792px;"></span>
<div style="position:absolute; top:50px;"><a name="1">Page 1</a></div>
<div style="position:absolute; border: textbox 1px solid; writing-mode:lr-tb; left:176px; top:108px; width:380px; height:125px;"><span style="font-family: Arial,Bold; font-size:11px">Jordi Salas-Salvadó, MD, PhD 
<br></span><span style="font-family: Arial; font-size:10px">Institution:</span><span style="font-family: Arial,Bold; font-size:10px"> </span><span style="font-family: Arial; font-size:10px">Human Nutrition Unit, Department of Biochemistry &amp; 
<br>Biotechnology, Sant Joan University Hospital, Faculty of Medicine of Reus, 
<br>Rovira i Virgili University, Spain; Pere Virgili Institute of Health Research; 
<br>CIBER Physiopathology of Obesity and Nutrition, Institute of Health Carlos III, 
<br>Spain.  Dr Salas Salvadó is Professor of Human Nutrition and Bromatology at 
<br>the Faculty of Medicine and Health Sciences (Rovira i Virgili University).  He 
<br>is Head of Nutrition of the Internal Medicine Service, Sant Joan University 
<br>Hospital of Reus and Vice-Dean / Head of Studies of the Degree in Human 
<br>Nutrition and Dietetics of the Rovira i Virgili University.  He is also 
<br></span></div><div style="position:absolute; border: textbox 1px solid; writing-mode:lr-tb; left:56px; top:236px; width:501px; height:286px;"><span style="font-family: Arial; font-size:10px">Distinguished Professor at the Universitat Rovira i Virgili.  In recent years, the expertise and research 
<br>lines of Dr Salas are focused on human clinical trials evaluating the effect of diets and dietary 
<br>compounds on obesity, type 2 diabetes mellitus, metabolic syndrome and cardiovascular disease. 
<br>Since 2005, he has been one of the leaders of PREDIMED STUDY, considered the best clinical trial 
<br>evaluating the effect of the Mediterranean Diet on cardiovascular diseases. He is the coordinator and 
<br>a member of the Steering Committee of the PREDIMED-PLUS STUDY, a multi-centre, randomised, 
<br>primary prevention trial on 6000 overweight or obese participants (55-75 years) with metabolic 
<br>syndrome. The project aim is to determine the effect on adiposity, cardiovascular disease and 
<br></span><span style="font-family: Arial; font-size:10px">mortality and quality of life, of an intensive weight loss intervention based on a traditional hypocaloric 
<br>Mediterranean Diet, physical activity promotion and behavioural therapy compared to a less intensive 
<br>program using Mediterranean diet (without energy restriction or physical activity). The recruitment 
<br>started in September 2013 and will finish in June 2016. Final results will be available in 2020.  Since 
<br>1983 Dr. Salas has directed 18 research projects financed by public bodies and 23 projects in 
<br>conjunction with the pharmaceutical or food industries. He has published more than 290 original 
<br>articles in national and international journals, as well as numerous reviews and editorials. Editor of 6 
<br>books, he has also co-authored more than 50 books. 
<br></span><span style="font-family: Arial; font-size:7px"> 
<br></span><span style="font-family: Arial,Bold; font-size:11px">A Mediterranean intensive lifestyle intervention: Predimed Plus</span><span style="font-family: Arial; font-size:11px"> 
<br></span><span style="font-family: Arial,Italic; font-size:9px">Jordi Salas Salvadó</span><span style="font-family: Arial,Italic; font-size:6px">a</span><span style="font-family: Arial,Italic; font-size:9px"> for the PREDIMED – Plus study investigators</span><span style="font-family: Arial; font-size:9px"> 
<br></span><span style="font-family: Arial,Italic; font-size:6px">a</span><span style="font-family: Arial,Italic; font-size:9px">Human  Nutrition  Unit,  Hospital  Universitari  de  Sant  Joan  de  Reus,  Faculty  of  Medicine  and  Health  Sciences, 
<br>IISPV  (Institut  d’Investigació Sanitària  Pere  Virgili),  Department  of  Biochemistry  and  Biotechnology,  Universitat 
<br>Rovira i Virgili, Reus, Spain, and b CIBERobn (Centro de Investigación Biomédica en Red Fisiopatología de la 
<br>Obesidad y Nutrición), Institute of Health Carlos III, Madrid, Spain. 
<br></span><span style="font-family: Arial; font-size:4px"> 
<br></span></div><div style="position:absolute; border: textbox 1px solid; writing-mode:lr-tb; left:56px; top:525px; width:500px; height:162px;"><span style="font-family: Arial; font-size:10px">There are no large randomized clinical trials in overweight subjects evaluating the effect of a long-term 
<br>sustained intentional weight loss using a healthy diet and physical activity promotion on the risk of 
<br>cardiovascular clinical events. The PREDIMED Plus study is a randomized, multicenter, parallel-group 
<br>trial for the primary prevention of cardiovascular disease (CVD). Six thousand men and woman 
<br>without prior CVD, aged between 55 – 75 years, with metabolic syndrome and body mass index 
<br>between 27- 40 kg/m</span><span style="font-family: Arial; font-size:6px">2 </span><span style="font-family: Arial; font-size:10px">(&lt;25% of them with diabetes) will be recruited by primary care medical doctors 
<br></span><span style="font-family: Arial; font-size:10px">affiliated to 22 centers throughout Spain to evaluate the effect of an intensive energy-restricted 
<br></span><span style="font-family: Arial; font-size:10px">Mediterranean diet, physical activity promotion and behavioral treatment, versus a control group 
<br></span><span style="font-family: Arial; font-size:10px">receiving low-intensity recommendations to follow a Mediterranean diet. The mail outcomes are: 
<br></span><span style="font-family: Arial; font-size:10px">incidence of CVD, weight loss and maintenance, quality of life, incidence of other chronic diseases 
<br>related to obesity, changes in CVD risk factors, and use of medication.  The results of this novel 
<br></span><span style="font-family: Arial; font-size:10px">clinical trial will contribute to provide a strong evidence to develop guidelines for overweight 
<br>management aimed to the primary prevention of CVD. 
<br></span></div><div style="position:absolute; border: textbox 1px solid; writing-mode:lr-tb; left:56px; top:688px; width:1px; height:4px;"><span style="font-family: Arial,Italic; font-size:4px"> 
<br></span></div><div style="position:absolute; border: textbox 1px solid; writing-mode:lr-tb; left:252px; top:696px; width:110px; height:10px;"><span style="font-family: Arial,Bold; font-size:10px">Learning objectives:</span><span style="font-family: Arial,BoldItalic; font-size:10px"> 
<br></span></div><div style="position:absolute; border: textbox 1px solid; writing-mode:lr-tb; left:56px; top:709px; width:498px; height:9px;"><span style="font-family: Arial; font-size:9px">1.  Any trial has never demonstrated that weight loss and maintenance reduces the risk of cardiovascular events 
<br></span></div><div style="position:absolute; border: textbox 1px solid; writing-mode:lr-tb; left:70px; top:720px; width:62px; height:9px;"><span style="font-family: Arial; font-size:9px">and mortality. 
<br></span></div><div style="position:absolute; border: textbox 1px solid; writing-mode:lr-tb; left:56px; top:732px; width:479px; height:9px;"><span style="font-family: Arial; font-size:9px">2.  The PREDIMED-Plus study is a randomized, multicentre, parallel group trial for the primary prevention of 
<br></span></div><div style="position:absolute; border: textbox 1px solid; writing-mode:lr-tb; left:70px; top:743px; width:107px; height:9px;"><span style="font-family: Arial; font-size:9px">cardiovascular disease. 
<br></span></div><div style="position:absolute; border: textbox 1px solid; writing-mode:lr-tb; left:56px; top:755px; width:483px; height:9px;"><span style="font-family: Arial; font-size:9px">3.  An intensive energy-restricted healthy diet with physical activity promotion and behavioural treatment may 
<br></span></div><div style="position:absolute; border: textbox 1px solid; writing-mode:lr-tb; left:70px; top:767px; width:132px; height:9px;"><span style="font-family: Arial; font-size:9px">have multiple health benefits. 
<br></span></div><div style="position:absolute; border: textbox 1px solid; writing-mode:lr-tb; left:56px; top:781px; width:13px; height:24px;"><span style="font-family: ABCDEE+Calibri; font-size:11px">41 
<br> 
<br></span></div><span style="position:absolute; border: black 1px solid; left:50px; top:693px; width:0px; height:0px;"></span>
<span style="position:absolute; border: black 1px solid; left:50px; top:693px; width:0px; height:0px;"></span>
<span style="position:absolute; border: black 1px solid; left:51px; top:693px; width:509px; height:0px;"></span>
<span style="position:absolute; border: black 1px solid; left:560px; top:693px; width:0px; height:0px;"></span>
<span style="position:absolute; border: black 1px solid; left:560px; top:693px; width:0px; height:0px;"></span>
<span style="position:absolute; border: black 1px solid; left:50px; top:693px; width:0px; height:13px;"></span>
<span style="position:absolute; border: black 1px solid; left:560px; top:693px; width:0px; height:13px;"></span>
<span style="position:absolute; border: black 1px solid; left:50px; top:707px; width:0px; height:11px;"></span>
<span style="position:absolute; border: black 1px solid; left:560px; top:707px; width:0px; height:11px;"></span>
<span style="position:absolute; border: black 1px solid; left:50px; top:718px; width:0px; height:11px;"></span>
<span style="position:absolute; border: black 1px solid; left:560px; top:718px; width:0px; height:11px;"></span>
<span style="position:absolute; border: black 1px solid; left:50px; top:730px; width:0px; height:11px;"></span>
<span style="position:absolute; border: black 1px solid; left:560px; top:730px; width:0px; height:11px;"></span>
<span style="position:absolute; border: black 1px solid; left:50px; top:741px; width:0px; height:11px;"></span>
<span style="position:absolute; border: black 1px solid; left:560px; top:741px; width:0px; height:11px;"></span>
<span style="position:absolute; border: black 1px solid; left:50px; top:753px; width:0px; height:11px;"></span>
<span style="position:absolute; border: black 1px solid; left:560px; top:753px; width:0px; height:11px;"></span>
<span style="position:absolute; border: black 1px solid; left:50px; top:777px; width:0px; height:0px;"></span>
<span style="position:absolute; border: black 1px solid; left:50px; top:777px; width:0px; height:0px;"></span>
<span style="position:absolute; border: black 1px solid; left:51px; top:777px; width:509px; height:0px;"></span>
<span style="position:absolute; border: black 1px solid; left:560px; top:777px; width:0px; height:0px;"></span>
<span style="position:absolute; border: black 1px solid; left:560px; top:777px; width:0px; height:0px;"></span>
<span style="position:absolute; border: black 1px solid; left:50px; top:764px; width:0px; height:12px;"></span>
<span style="position:absolute; border: black 1px solid; left:560px; top:764px; width:0px; height:12px;"></span>
<div style="position:absolute; border: figure 1px solid; writing-mode:False; left:58px; top:108px; width:108px; height:124px;"><div style="position:absolute; border: figure 1px solid; writing-mode:False; left:43px; top:108px; width:143px; height:183px;"></div></div><span style="position:absolute; border: black 1px solid; left:58px; top:108px; width:108px; height:125px;"></span>
<div style="position:absolute; top:0px;">Page: <a href="#1">1</a></div>
</body></html>
